Is nolvadex (tamoxifen) for getting rid of man breasts or not?

Not intended for. This drug is not intended for this but i understand that there are a few endocrinologists who are using this in an off label fashion for this purpose and there are some illicit anabolic steroid body builders who use this to minimize the development of male breasts. It generally will not reverse existing breast tissue or we would use if for female breast reduction.

Related Questions

Can you use nolvadex (tamoxifen) to get rid of gynecomastia?

Yes. Although tamoxifen is not fda-approved for this use, multiple studies have been published demonstrating it's benefit treating gynecomastia. It is probably most beneficial early in the development of the disease. If no effect is seen after three months, continuing the drug further is probably not helpful. Read more...
Unlikely. Once the breast tissue has grown and developed into true glandular gynecomastia only surgical treatment is effective. Read more...
Maybe. Nolvadex (tamoxifen) is effective in reducing estrogen driven gynecomastia. It works to prevent better than to treat the problem and is given prophyllactically when men are given Estrogens to treat various disease states. Read more...

What is the role of tamoxifen in the treatment of breast cancer?

Chemotherapy. Tamoxifen is a very effective drug for the treatment of hormone-sensitive (estrogen receptor +) breast cancers. It may be used alone or in combination with traditional IV chemotherapy, depending on the cancer stage. Furthermore, tamoxifen has been shown to be effective reducing the chance of developing breast cancer in high-risk women ("chemoprevention"). Read more...
Anti-estrogen. Tamoxifen is one of the anti-estrogen agents used to treat breast cancer. Cancers that exhibit an estrogen receptor (er positive tumors) are treated in part by blocking the estrogen that act as signals to these tumors to grow. Read more...

Does tamoxifen help prevent breast cancer?

Yes. Tamoxifen use may reduce the development of breast cancer in high-risk patients by about 50%. There are risks associated with tamoxifen, so the decision whether to take this medication is based upon an individual patient's risk:benefit analysis. Read more...
Yes - ER+ breast CA. The p-1 trial showed in high risk women tamoxifen decreased the risk of er+ tumors by 40-50% (no difference in er- tumors) over palcebo. The p-2 or star trial compared tamoxifen to raloxifene/evista and saw similar overall benefits with some slight variations. Recently, a new trial has shown 65% reduction benefit for the aromatase inhibitor Exemestane over placebo. Read more...
Recurrence. It prevents recurrence in women with estrogen receptor positive tumors. Read more...
And new primaries. Tamoxifen blocks estrogen and Progesterone receptors which when stimulated can cause remnant cancer cells to be stimulated to grow back and also can cause normal cells to be overstimulated to develop into new hormonally sensitive cancer. Statistically it reduces the chance of recurrence by 30% and reduces the chance of a second primary by 50%. Read more...
Secondary Prevention. Tamoxifen also can be used to prevent breast cancer in the other breast as well as "secondary prevention" of breast cancer in patients who are at higher than normal risk of developing breast cancer. Read more...

When is tamoxifen for breast cancer treatment?

See below. Tamoxifen can be used after other treaments such as surgery, radiation and chemotherapy to prevent a cancer recurrence, or it can be used if cancer has spread in order to slow it's growth. Read more...
Chemotherapy. Tamoxifen is a very effective drug for the treatment of hormone-sensitive (estrogen receptor +) breast cancers. It may be used alone or in combination with traditional IV chemotherapy, depending on the cancer stage. Furthermore, tamoxifen has been shown to be effective reducing the chance of developing breast cancer in high-risk women ("chemoprevention"). Read more...

What are the risks of breast cancer returning within a year of original treatment if taking tamoxifen?

Hopefully low. But highly dependent on your history, the type of breast cancer, size of tumor or if lymph nodes were involved, hormone receptor status, if radiation therapy was given, type of surgery, etc. Would need much more detailed information than can be answered here. Your medical oncologist would be the best resource to this question for your own specific situation. Read more...
Low. Most women do well if their tumor is removed and it is in early stages...With high cure rates of 80-85% for stages 1 and 2.. The chances of return within one year of orginal diagnosis have to be very low, perhaps about 5% in my view. Read more...

Is tamoxifen a must for er/pr negative menstruating woman for breast cancer treatment?

No. Actually, it's er/pr positive women who are potential candidates for tamoxifen. This is advised for women whose cancer stage mandates chemotherapy, sometimes combined with traditional IV chemotherapy. Furthermore, we often recommend tamoxifen to prevent the development of a second cancer is breast cancer survivors. Read more...
No. This and similar medicines are anti Estrogens that block the receptors. So if the patient has negative receptors there is little benefit from the medication. So it's not a must. Read more...

Is it okay for an oncologist to do breast cancer treatment without tamoxifen?

Yes. Tamoxifen is a very effective drug for the treatment of hormone-sensitive (estrogen receptor +) breast cancers. It may be used alone or in combination with traditional IV chemotherapy, depending on the cancer stage. It has no role in rx of estrogen (-) breast ca. Furthermore, aromatase inhibitors are an effective alternative to tamoxifen for estrogen (+) breast cancer after menopause. Read more...
Yes! Tamoxifen is only useful in breast cancers which are estrogen receptor positive(er+). So tamoxifen is of no use if the tumor is er negative. Check your tumor's hormone receptor status and you will have the answer to your question>. Read more...